Gynecologic Oncology Group

This study is testing whether a combination of two oral drugs, ribociclib and letrozole, can help control recurrent low-grade serous cancer of the ovary, fallopian tube, or peritoneum. It is for women whose cancer has returned after prior treatment. The goal is to see if this com…

This study is testing whether a combination of two existing drugs, abemaciclib and letrozole, can stop advanced or recurrent endometrial cancer from getting worse for at least six months. It involves about 53 women whose cancer has spread or returned and is not likely curable by …